Arnhold and S. Bleichroeder

Arnhold and S. Bleichroeder was a prestigious New York-based investment bank and asset management firm with a history dating back to 19th-century Germany. The firm was highly regarded for its research-driven, value-oriented investment style and its focus on international securities, most notably through the First Eagle group of mutual funds. While not a biotechnology company itself, the firm was a significant early investor in the life sciences sector, providing critical backing to companies like Celgene during their formative years. In 2009, the firm's asset management business was rebranded as First Eagle Investment Management, effectively retiring the Arnhold and S. Bleichroeder name from primary retail operations. The Arnhold family remains influential in the healthcare space through significant philanthropy, including the Arnhold Institute for Global Health at Mount Sinai.